-
Subject Areas on Research
-
5-HTTLPR and use of antidepressants after colorectal cancer including a meta-analysis of 5-HTTLPR and depression after cancer.
-
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.
-
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
-
A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom?
-
A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
-
A combined treatment approach to anxiety in the medically ill.
-
A comparison of alternative assessments of depressive symptom severity: a pilot study.
-
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
-
A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs.
-
A double-blind comparison of bupropion and amitriptyline in depressed inpatients.
-
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).
-
A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
-
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
-
A global logrank test for adaptive treatment strategies based on observational studies.
-
A history of the concept of atypical depression.
-
A longitudinal evaluation of adolescent depression and adult obesity.
-
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
-
A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
-
A practical approach to the early identification of antidepressant medication non-responders.
-
A preliminary metabolomic analysis of older adults with and without depression.
-
A prescription for unemployment? Recessions and the demand for mental health drugs.
-
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.
-
A randomized controlled trial of paroxetine for noncardiac chest pain.
-
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
-
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
-
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
-
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.
-
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
-
A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
-
A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
-
A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder.
-
A systematic review of treatments for refractory depression in older people.
-
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
-
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
-
Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool.
-
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
-
Adinazolam sustained-release treatment of panic disorder: a double-blind study.
-
Adjunctive brexpiprazole for the treatment of major depressive disorder.
-
Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression.
-
Advances in Pharmacotherapy of Late-Life Depression.
-
Advances in opioid antagonist treatment for opioid addiction.
-
Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
-
Algorithms For Treatment of Major Depressive Disorder: Efficacy and Cost-Effectiveness.
-
Algorithms for optimizing the treatment of depression: making the right decision at the right time.
-
Alprazolam in bipolar-I depressions.
-
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.
-
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome.
-
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
-
An application of the revised CONSORT standards to FDA summary reports of recently approved antidepressants and antipsychotics.
-
An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
-
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
-
An overview of the clinical rationale for advancing gender-related psychopharmacology and drug abuse research.
-
Angiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men.
-
Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.
-
Antidepressant Use and Depressive Symptoms in Intensive Care Unit Survivors.
-
Antidepressant Use in a 3- to 12-Year Follow-up of Anxious Youth: Results from the CAMELS Trial.
-
Antidepressant Use, Depression, and Poor Cardiovascular Outcomes: The Chicken or the Egg?: Comment on "Antidepressant Use and Risk of Incident Cardiovascular Morbidity and Mortality Among Postmenopausal Women in the Women's Health Initiative Study".
-
Antidepressant actions of histone deacetylase inhibitors.
-
Antidepressant effects of nicotine in an animal model of depression.
-
Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.
-
Antidepressant medication use [corrected] and risk of ovarian cancer.
-
Antidepressant medication use in palliative care.
-
Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.
-
Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion.
-
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report.
-
Antidepressant therapy in patients with ischemic heart disease.
-
Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.
-
Antidepressant use and the risk of myocardial infarction.
-
Antidepressant use by race.
-
Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization.
-
Antidepressant use, depression, and survival in patients with heart failure.
-
Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats.
-
Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.
-
Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats.
-
Antidepressants in chronic pain syndromes.
-
Antidepressants in inflammatory bowel disease.
-
Are Cosmetic Procedures Comparable to Antidepressive Medication for Quality-of-Life Improvements? A Systematic Review and Controlled Meta-Analysis.
-
Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
-
Are psychiatrists' characteristics related to how they care for depression in the medically ill? Results from a national case-vignette survey.
-
Assessing anxious features in depressed outpatients.
-
Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.
-
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.
-
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
-
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
-
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease.
-
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
-
Atypical depression: a comprehensive review.
-
Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St John's wort treatment.
-
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
-
Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
-
Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
-
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
-
Behavioral effects of short-term administration of lithium and valproic acid in rats.
-
Behavioral treatment of obsessive-compulsive neurosis.
-
Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.
-
Benzodiazepines as antidepressants: does GABA play a role in depression?
-
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.
-
Best clinical practice: guidelines for managing major depression in primary medical care.
-
Better, Faster, Safer: Exploring Biomarkers of Response to Transform Electroconvulsive Therapy.
-
Biological and cognitive predictors of response to acute treatment in depressed outpatients.
-
Biological and social predictors of long-term geriatric depression outcome.
-
Biological therapies for posttraumatic stress disorder: an overview.
-
Bipolar Depression: Pregnancy, Postpartum, and Lactation.
-
Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy.
-
Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.
-
Bupropion dosing recommendations.
-
Bursts and the efficacy of selective serotonin reuptake inhibitors.
-
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
-
Cannabinoids. Synthesis and central nervous system activity of 8-substituted 10-hydroxy-5,5-dimethyl-5H-[1]benzopyrano[4,3-c]pyridine and derivatives.
-
Case report of treatment of severe mood disorder in an inpatient setting: when less is more.
-
Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine.
-
Catching up on health outcomes: the Texas Medication Algorithm Project.
-
Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
-
Changes in depressive symptoms and social functioning in the sequenced treatment alternatives to relieve depression study.
-
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
-
Cholinergic-adrenergic hypothesis of mania and depression.
-
Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
-
Chronic pain and depression.
-
Cingulum bundle white matter lesions influence antidepressant response in late-life depression: a pilot study.
-
Circadian Preference as a Moderator of Depression Outcome Following Cognitive Behavioral Therapy for Insomnia Plus Antidepressant Medications: A Report From the TRIAD Study.
-
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
-
Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.
-
Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients.
-
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
-
Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression.
-
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
-
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.
-
Clinical experience with substance P receptor (NK1) antagonists in depression.
-
Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D.
-
Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.
-
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
-
Clinical outcomes of older depressed patients with and without comorbid neuroticism.
-
Clinical practice guidelines for managing major depression in primary care practice. Implications for psychologists. U.S. Public Health Service Agency for Health Care Policy and Research.
-
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.
-
Clinical trial evidence for treatment of depression in heart failure.
-
Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
-
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review.
-
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.
-
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
-
Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.
-
Combining antidepressant medications: a good idea?
-
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
-
Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
-
Comorbidities in patients with all-positive symptoms on sinonasal outcomes test quality-of-life instrument.
-
Comorbidity and depression treatment.
-
Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
-
Comparative effectiveness of dual vs. single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
-
Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
-
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy.
-
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study.
-
Comparison of brain structural variables, neuropsychological factors, and treatment outcome in early-onset versus late-onset late-life depression.
-
Competing demands: Does care for depression fit in primary care?
-
Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.
-
Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial".
-
Consensus guidelines in the treatment of major depressive disorder.
-
Consensus statement on depression, anxiety, and oncology.
-
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
-
Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety.
-
Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety.
-
Contemporary management of comorbid anxiety and depression in geriatric patients.
-
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
-
Correlates of remission in primary care patients treated for minor depression.
-
Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment.
-
Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.
-
Cyclophosphamide-induced cystitis results in NLRP3-mediated inflammation in the hippocampus and symptoms of depression in rats.
-
DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action.
-
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.
-
Datapoints: Use of medications and counseling for depression by Asian and multiple-race adolescents aged 12-17 years.
-
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses.
-
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
-
Depression after myocardial infarction.
-
Depression and antidepressant use after stroke and transient ischemic attack.
-
Depression and cardiac risk.
-
Depression and cognition in the elderly.
-
Depression and insomnia in women.
-
Depression and insulin resistance: applications to polycystic ovary syndrome.
-
Depression and ischemic heart disease.
-
Depression and ischemic heart disease: what have we learned from clinical trials?
-
Depression and ischemic heart disease: what have we learned so far and what must we do in the future?
-
Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.
-
Depression in late life.
-
Depression in long-term care.
-
Depression in the elderly.
-
Depression outcome in inpatients with congestive heart failure.
-
Depression treatment in a sample of 1,801 depressed older adults in primary care.
-
Depression, IV: STAR*D treatment trial for depression.
-
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
-
Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database.
-
Depressive Symptoms and Risk of Cardiovascular Events in Blacks: Findings From the Jackson Heart Study.
-
Depressive characteristics of FSL rats: involvement of central nicotinic receptors.
-
Depressive disorders in older medical inpatients.
-
Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study.
-
Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder.
-
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.
-
Diagnostic Accuracy of Screening Tests and Treatment for Post-Acute Coronary Syndrome Depression: A Systematic Review.
-
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
-
Differential effects of the antidepressant mirtazapine on amphetamine- and dizocilpine-induced PPI deficits.
-
Differential response to SSRI versus Placebo and distinct neural signatures among data-driven subgroups of patients with major depressive disorder.
-
Difficult behaviors in long-term care patients with dementia.
-
Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United States.
-
Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
-
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
-
Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
-
Does antidepressant therapy improve cognition in elderly depressed patients?
-
Does medication adherence following a copayment increase differ by disease burden?
-
Does minocycline have antidepressant effect?
-
Does neurotropin-3 have a therapeutic implication in major depression?
-
Does pretreatment anxiety predict response to either bupropion SR or sertraline?
-
Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and design.
-
Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes.
-
Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
-
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
-
Duloxetine: an emerging evidence for fibromyalgia.
-
Durability of antidepressant response to vagus nerve stimulation (VNS).
-
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
-
Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects.
-
Dyspepsia.
-
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial.
-
ERICH3: vesicular association and antidepressant treatment response.
-
Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.
-
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.
-
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial.
-
Eating disorders.
-
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
-
Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
-
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
-
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
-
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
-
Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.
-
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.
-
Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial.
-
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects.
-
Effectiveness of chromium in atypical depression: a placebo-controlled trial.
-
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
-
Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study.
-
Effects of a Course of Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy Combined With Venlafaxine on Insomnia Symptoms in Elderly Depressed Patients.
-
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
-
Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.
-
Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.
-
Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy.
-
Effects of exercise training on older patients with major depression.
-
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial.
-
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.
-
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
-
Efficacy and safety of St. John's wort for the treatment of major depression.
-
Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis.
-
Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
-
Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
-
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
-
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
-
Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
-
Efficacy of treatments for major depression.
-
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials.
-
Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.
-
Efficient trial designs to reduce placebo requirements.
-
Electric field causes volumetric changes in the human brain.
-
Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.
-
Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes.
-
Electroconvulsive therapy: how effective is it?
-
Elevation in plasma Abeta42 in geriatric depression: a pilot study.
-
Emergence of anxiety-like behaviours in depressive-like Cpe(fat/fat) mice.
-
Emergent anxiety after antidepressant initiation: a retrospective cohort study of Veterans Affairs Health System patients with depression.
-
Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators.
-
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants.
-
Enrolling research subjects from clinical practice: ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.
-
Escitalopram related edema in a patient with Hashimoto's thyroiditis.
-
Ethnic differences in the treatment of depression in patients with ischemic heart disease.
-
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
-
Evidence-based treatment of psychiatric disorders with comorbid medical illnesses: the need for large simple clinical trials.
-
Examination of the utility of psychotherapy for patients with treatment resistant depression: a systematic review.
-
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
-
Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study.
-
Exercise and pharmacotherapy in the treatment of major depressive disorder.
-
Exercise fails to improve neurocognition in depressed middle-aged and older adults.
-
Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure.
-
Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months.
-
Exposure to SSRI-type antidepressants increases righting time in the marine snail Ilyanassa obsoleta.
-
Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets.
-
Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.
-
Factors that differentiate early vs. later onset of major depression disorder.
-
Family history of depression and therapeutic outcome: findings from STAR*D.
-
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
-
Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon.
-
Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype.
-
First-line pharmacotherapy approaches for generalized anxiety disorder.
-
Folate and unipolar depression.
-
Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression.
-
Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment.
-
Frequency of high-risk use of QT-prolonging medications.
-
From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs.
-
Frontal white matter anisotropy and antidepressant remission in late-life depression.
-
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
-
Functional Dyspepsia.
-
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
-
Further studies on platelet serotonin transporter binding in depression.
-
Gender differences in antidepressant and activating-drug effects on self-perceptions
-
Gender, depressive subtypes, and gender-age effects on antidepressant response: Hormonal hypotheses
-
Generalized anxiety disorder and irritable bowel syndrome.
-
Generalized anxiety disorder. An important clinical concern.
-
Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.
-
Goodness-of-fit tests for GEE modeling with binary responses.
-
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
-
Hippocampal volume and antidepressant response in geriatric depression.
-
Hippocampus atrophy and the longitudinal course of late-life depression.
-
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
-
I-CARE randomized clinical trial integrating depression and acute coronary syndrome care in low-resource hospitals in China: Design and rationale.
-
Identifying depression in primary care: a literature synthesis of case-finding instruments.
-
Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans.
-
Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.
-
Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression.
-
Impact of hospital type II violent events: use of psychotropic drugs and mental health services.
-
Impact of pain on the outcomes of depression treatment: results from the RESPECT trial.
-
Impacts of depression and emotional distress on cardiac disease.
-
Impaired cholecystokinin secretion in bulimia nervosa.
-
Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
-
Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.
-
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.
-
Improving Depression Outcome by Patient-Centered Medical Management.
-
Improving depression care for older, minority patients in primary care.
-
Improving depression outcomes in older adults with comorbid medical illness.
-
Improving primary care for depression in late life: the design of a multicenter randomized trial.
-
Improving the chance of recovery from the short- and long-term consequences of depression.
-
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.
-
Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.
-
Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.
-
Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample.
-
Indicators of pretreatment suicidal ideation in adults with major depressive disorder.
-
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.
-
Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians.
-
Insight and treatment outcome in obsessive-compulsive disorder.
-
Insured and non-insured depressed outpatients: how do they compare?
-
International consensus statement on major depressive disorder.
-
Intravenous Ketamine Relieves Pain and Depression After Traumatic Suicide Attempts: A Case Series.
-
Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test.
-
Is there a definition of remission in late-life depression that predicts later relapse?
-
Isn't It About Time to Employ Measurement-Based Care in Practice?
-
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
-
Ketamine for treatment-resistant depression: ready or not for clinical use?
-
Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3.
-
Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review.
-
Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias.
-
Late-life depression: how to treat patients with comorbid chronic illness. Interview by Alice V. Luddington.
-
Lessons from SADHART, ENRICHD, and other trials.
-
Limitations in efficacy of antidepressant monotherapy.
-
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.
-
Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN).
-
Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population.
-
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression.
-
Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
-
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
-
Major depression, antidepressant use, and male and female fertility.
-
Major depressive disorder treatment guidelines in America and Europe.
-
Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.
-
Marked differences in antidepressant use by race in an elderly community sample: 1986-1996.
-
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
-
Measurement of depression treatment among patients receiving HIV primary care: Whither the truth?
-
Measurement-based care in psychiatric practice: a policy framework for implementation.
-
Medication adherence in combat veterans with traumatic brain injury.
-
Meeting the needs of primary care physicians: a guide to content for programs on depression.
-
Metabolomic signatures of intravenous racemic ketamine associated remission in treatment-resistant depression: A pilot hypothesis generating study.
-
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
-
Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial.
-
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants.
-
Milnacipran: beyond a role of antidepressant.
-
Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort.
-
Minor depression and physical outcome trajectories in heart failure and pulmonary disease.
-
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement.
-
Mood disorders and chronic obstructive pulmonary disease: current research and future needs.
-
Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
-
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
-
National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder.
-
Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence.
-
Neural mechanisms of cognitive reappraisal in remitted major depressive disorder.
-
Neurocognitive correlates of response to treatment in late-life depression.
-
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
-
New Developments in Insomnia Medications of Relevance to Mental Health Disorders.
-
New concepts in the diagnosis and management of depression.
-
New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression.
-
Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
-
Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.
-
Nonpharmacologic treatments for depression in patients with coronary heart disease.
-
One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes.
-
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies.
-
Onset of alcohol or substance use disorders following treatment for adolescent depression.
-
Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression.
-
Overview of psychiatric disorders and the role of newer antidepressants.
-
Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
-
Panic disorder: making clinical sense of the latest research.
-
Parental marital discord and treatment response in depressed adolescents.
-
Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care.
-
Patterns of antidepressant therapy and clinical outcomes among ischaemic stroke survivors.
-
Pediatric pain syndromes and management of pain in children and adolescents with rheumatic disease.
-
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
-
Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
-
Pharmacological agents to treat severe neuropsychiatric symptoms in major neurocognitive disorders.
-
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.
-
Pharmacotherapy of generalized anxiety disorder.
-
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.
-
Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action.
-
Physician office visits of adults for anxiety disorders in the United States, 1985-1998.
-
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.
-
Plasma omega-3 polyunsaturated fatty acids and survival in patients with chronic heart failure and major depressive disorder.
-
Polysomnographic findings in recently drug-free and clinically remitted depressed patients.
-
Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers.
-
Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.
-
Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment.
-
Potential effects of common drugs on stroke recovery.
-
Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association.
-
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.
-
Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.
-
Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
-
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings.
-
Predictors of antidepressant use among older adults: have they changed over time?
-
Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention.
-
Predictors of depression outcomes in medical inpatients with chronic pulmonary disease.
-
Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.
-
Predictors of recurrence in remitted late-life depression.
-
Prefrontal neuropsychological predictors of treatment remission in late-life depression.
-
Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study.
-
Presence of neuroticism and antidepressant remission rates in late-life depression: results from the Neurobiology of Late-Life Depression (NBOLD) study.
-
Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder.
-
Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial.
-
Prevalence of depression and its treatment in an elderly population: the Cache County study.
-
Primary care physicians' and psychiatrists' approaches to treating mild depression.
-
Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D.
-
Progression of subcortical ischemic disease from vascular depression to vascular dementia.
-
Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression.
-
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
-
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
-
Provider characteristics related to antidepressant use in older people.
-
Providers' attitudes towards treating depression and self-reported depression treatment practices in HIV outpatient care.
-
Psychological discomfort and mental illness in patients with AIDS: implications for home care.
-
Psychopharmacological treatment for very young children: contexts and guidelines.
-
Psychosocial and clinical predictors of unipolar depression outcome in older adults.
-
Psychosocial context of antidepressant response.
-
Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?
-
Psychotropic drug use in late life: a diverse look at an expanding field.
-
Psychotropic drugs on general medical and surgical wards of a teaching hospital.
-
Quetiapine XR: current status for the treatment of major depressive disorder.
-
RU486 in depression.
-
Racial differences in antidepressant treatment preceding suicide in a Medicaid population.
-
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
-
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
-
Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
-
Rational treatment choices for non-major depressions in primary care: an evidence-based review.
-
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
-
Rationale, design, and baseline data for a multicenter randomized clinical trial comparing depression screening strategies after acute coronary syndrome: The comparison of depression identification after acute Coronary Syndromes-Quality of Life and Cost Outcomes (CODIACS-QOL) trial.
-
Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression.
-
Recent advances in poststroke depression.
-
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.
-
Relapse of depression after electroconvulsive therapy.
-
Relapse of depressive symptoms after discontinuing sertraline.
-
Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication.
-
Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.
-
Relationship of pharmaceutical promotion to antidepressant switching and adherence: a retrospective cohort study.
-
Religiosity and remission of depression in medically ill older patients.
-
Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale.
-
Remissions in maternal depression and child psychopathology: a STAR*D-child report.
-
Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial.
-
Research design features and patient characteristics associated with the outcome of antidepressant clinical trials.
-
Research issues in the study of difficult-to-treat depression.
-
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.
-
Response characteristics to antidepressants and placebo in post-traumatic stress disorder.
-
Response inhibition predicts poor antidepressant treatment response in very old depressed patients.
-
Retention and attrition among African Americans in the STAR*D study: what causes research volunteers to stay or stray?
-
STAR*D: revising conventional wisdom.
-
STAR*D: what have we learned?
-
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
-
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
-
Sampling of empirically supported psychological treatments from health psychology: smoking, chronic pain, cancer, and bulimia nervosa.
-
Scopolamine sleep treatment in private practise.
-
Secondary agoraphobia: two case reports.
-
Seizures and bupropion: a review.
-
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
-
Self-rated global measure of the frequency, intensity, and burden of side effects.
-
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
-
Sertraline as a first-line treatment for cholestatic pruritus.
-
Sertraline for treatment of depression in acute coronary syndromes.
-
Sertraline in children and adolescents with social anxiety disorder: an open trial.
-
Sexual functioning of men and women with severe obesity before bariatric surgery.
-
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial.
-
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
-
Sleep therapeutics and neuropsychiatric illness.
-
Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment.
-
Social phobia: biological aspects and pharmacotherapy.
-
Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population.
-
Sociotropy and autonomy: relationship to antidepressant drug treatment response and endogenous-nonendogenous dichotomy.
-
Special aspects of neuropsychiatric illness in women: With a focus on depression
-
Speed of response to electroconvulsive therapy compared with ketamine.
-
Spousal depression, anxiety, and suicide after myocardial infarction.
-
Star-D: lessons learned and future implications.
-
Strategies and tactics in the management of maintenance treatment for depressed patients.
-
Strategies and tactics in the treatment of chronic depression.
-
Strengthening clinical effectiveness trials: equipoise-stratified randomization.
-
Stress-induced muscle and cutaneous hyperalgesia: differential effect of milnacipran.
-
Structural brain changes as biomarkers and outcome predictors in patients with late-life depression: a cross-sectional and prospective study.
-
Study protocol for evaluating the effectiveness of depression management on gylcaemic control in non-communicable diseases clinics in Malawi.
-
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
-
Suicidality as a possible side effect of antidepressant treatment.
-
Suicide risk analysis among patients assigned to psychotropics and placebo.
-
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
-
Targeting treatments for depression: what can our patients tell us?
-
Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.
-
The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
-
The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.
-
The Effect of Antidepressants on the Course of Inflammatory Bowel Disease.
-
The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.
-
The Natural Course of Adolescent Depression Treatment in the Primary Care Setting.
-
The STAR*D study: treating depression in the real world.
-
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
-
The Treatment for Adolescents With Depression Study (TADS): demographic and clinical characteristics.
-
The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial.
-
The Use of Antidepressants in Bipolar Depression.
-
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).
-
The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease.
-
The changing perspective on chronic insomnia management.
-
The clinical relevance of self-reported premenstrual worsening of depressive symptoms in the management of depressed outpatients: a STAR*D report.
-
The cost consequences of treatment-resistant depression.
-
The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.
-
The effectiveness of depression care management on diabetes-related outcomes in older patients.
-
The effects of antidepressant medication adherence as well as psychosocial and clinical factors on depression outcome among older adults.
-
The effects of nefazodone on sleep architecture in depression.
-
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
-
The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.
-
The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment.
-
The pharmacologic management of insomnia in patients with HIV.
-
The relationship between fibromyalgia and major depressive disorder: a comprehensive review.
-
The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients.
-
The sea urchin embryo as a model for mammalian developmental neurotoxicity: ontogenesis of the high-affinity choline transporter and its role in cholinergic trophic activity.
-
The treatment effectiveness project. A comparison of the effectiveness of paroxetine, problem-solving therapy, and placebo in the treatment of minor depression and dysthymia in primary care patients: background and research plan.
-
The treatment of primary insomnia.
-
The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?
-
The undertreatment of dysthymia.
-
The use of analgesics in the management of pain in rheumatic diseases.
-
The use of pharmacotherapies for smoking cessation during pregnancy.
-
The use of placebos in unipolar major depression: the current status.
-
Thyroid hormones affect recovery from depression during antidepressant treatment.
-
Tiagabine in treatment refractory bipolar disorder: a clinical case series.
-
Time-to-remission from geriatric depression: psychosocial and clinical factors.
-
Toward a Definition of "No Meaningful Benefit" From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales.
-
Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
-
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial.
-
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
-
Treating cognitive impairment in depression: an unmet need.
-
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians.
-
Treating insomnia in depression: Insomnia related factors predict long-term depression trajectories.
-
Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.
-
Treatment considerations for patients with neuropathic pain and other medical comorbidities.
-
Treatment considerations for the depressed geriatric medical patient.
-
Treatment course with antidepressant therapy in late-life depression.
-
Treatment of depression in the medically ill.
-
Treatment of depression--newer pharmacotherapies.
-
Treatment of depression.
-
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
-
Treatment of older adults with co-morbid personality disorder and depression: a dialectical behavior therapy approach.
-
Treatment of post-stroke depression with antidepressants.
-
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
-
Understanding the biological basis of psychiatric disease: What's next?
-
Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients.
-
Use of antidepressants for the treatment of psychiatric illnesses.
-
Use of antidepressants in medically ill older patients.
-
Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.
-
Use of the light/dark test for anxiety in adult and adolescent male rats.
-
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
-
Variability in sleep disturbance, physical activity and quality of life by level of depressive symptoms in women with Type 2 diabetes.
-
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
-
Vascular nutritional correlates of late-life depression.
-
Vmat2 heterozygous mutant mice display a depressive-like phenotype.
-
What are the new treatments for bipolar disorder?
-
What is the overlap between subjective and objective cognitive impairments in MDD?
-
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.
-
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
-
When at first you don't succeed: sequential strategies for antidepressant nonresponders.
-
Which depressions respond to placebo?
-
White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study.
-
White matter hyperintensity progression and late-life depression outcomes.
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.
-
Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale.
-
Keywords of People
-
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
Bradford, Daniel William,
Professor of Psychiatry and Behavioral Sciences,
Psychiatry, Child & Family Mental Health & Community Psychiatry
-
Curtis, Lesley H.,
Professor in Population Health Sciences,
Medicine, General Internal Medicine
-
Laskowitz, Daniel Todd,
Professor of Neurology,
Duke Science & Society
-
Nieuwsma, Jason A,
Associate Professor in Psychiatry and Behavioral Sciences,
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology
-
Olsen, Maren Karine,
Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Wu, Li-Tzy,
Professor in Psychiatry and Behavioral Sciences,
Medicine, General Internal Medicine